A detailed history of Ubs Oconnor LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Ubs Oconnor LLC holds 17,500 shares of JNJ stock, worth $2.72 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
17,500
Holding current value
$2.72 Million
% of portfolio
0.15%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$144.38 - $157.78 $2.6 Million - $2.84 Million
18,000 New
18,000 $2.63 Million
Q3 2022

Nov 14, 2022

BUY
$161.33 - $179.52 $1.79 Million - $1.99 Million
11,073 New
11,073 $1.81 Billion
Q1 2022

May 16, 2022

BUY
$158.14 - $179.59 $458,289 - $520,451
2,898 New
2,898 $513,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Ubs Oconnor LLC Portfolio

Follow Ubs Oconnor LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Oconnor LLC with notifications on news.